Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ML-016 in Advanced Solid Tumors With Lung and/or Liver Involvement
NCT07723482Phase 2Recruiting
- Sponsor
- BrYet
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ML-016 in solid tumor, sponsored by BrYet. Started Sep 2026; status: recruiting.
02
Drugs
ML-016
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07723482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07723482.